STROBER, B.; SOFEN, H.; IMAFUKU, S.; PAUL, C.; GOODERHAM, M.; SPELMAN, L.; SEO, S. J.; PASSERON, T.; KISA, R. M.; BERGER, V.; VRITZALI, E.; HOYT, K.; COLOMBO, M. J.; BANERJEE, S.; AUGUSTIN, M.; STEIN GOLD, L.; ALEXIS, A.; THAÇI, D.; BLAUVELT, A.; LEBWOHL, M. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s241, 2023. DOI: 10.25251/skin.7.supp.241. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2360. Acesso em: 3 jul. 2024.